Cargando…

Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study

Background: Due to the lack of updated information on teicoplanin (TEI) for continuous renal replacement therapy (CRRT), no exact dosage regimen has been recommended. The aim of this study was to optimize the dosage regimen of TEI in renal dysfunction patients with or without CRRT, evaluate the infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Lu, Zhuang, Zhiwei, Duan, Lufen, Zhu, Chenqi, Xue, Hongzhi, Wang, Xiao, Xu, Xiaowen, Yuan, Yunlong, Shi, Ling, Li, Jiahui, Sun, Jiantong, Liu, Xin, Zhou, Qin, Lu, Jian, Tang, Lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957950/ https://www.ncbi.nlm.nih.gov/pubmed/35350761 http://dx.doi.org/10.3389/fphar.2022.817401

Ejemplares similares

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

A Regression Model to Predict Linezolid Induced Thrombocytopenia in Neonatal Sepsis Patients: A Ten-Year Retrospective Cohort Study
por: Duan, Lufen, et al.
Publicado: (2022)

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Li, Lu, et al.
Publicado: (2020)

A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment
por: Tang, Lian, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study
por: Huang, Fang, et al.
Publicado: (2023)

The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital
por: Xu, Jinhui, et al.
Publicado: (2022)

Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Matusik, Elodie
Publicado: (2020)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients
por: Wu, Fan, et al.
Publicado: (2022)

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
por: Sime, Fekade B., et al.
Publicado: (2019)

Melatonin Alleviates Renal Injury in Mouse Model of Sepsis
por: Chen, Liyang, et al.
Publicado: (2021)

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model
por: Vossen, M G, et al.
Publicado: (2021)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
por: Wang, Yifan, et al.
Publicado: (2023)

Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance
por: Xu, Caifang, et al.
Publicado: (2022)

Impact of Healthcare Associated Infections on Survival and Treatment Outcomes Among End Stage Renal Disease Patients on Renal Replacement Therapy
por: Abbasi, Saad Hanif, et al.
Publicado: (2021)

Effect of replacement therapy (CRRT) and hemodialysis (IHD) on severe acute renal failure
por: Zhang, Xiangyuan, et al.
Publicado: (2023)

Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy
por: Wu, Lingping, et al.
Publicado: (2017)

Histone Acetylation and Modifiers in Renal Fibrosis
por: Shen, Fengchen, et al.
Publicado: (2022)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
por: Kang, Kai, et al.
Publicado: (2022)

Pharmacokinetics of metoclopramide in calves with renal dysfunction
por: TAKAYASU, Mariko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1u11ame38fd0b3j8r879ik91qo